Nothing Special   »   [go: up one dir, main page]

Cengiz et al., 2010 - Google Patents

Infectious mononucleosis in Turkish children

Cengiz et al., 2010

View PDF
Document ID
17020609428959808255
Author
Cengiz A
Cultu-Kantaroğlu O
Seçmeer G
Ceyhan M
Kara A
Gürgey A
Publication year
Publication venue
The Turkish journal of pediatrics

External Links

Snippet

The aim of this study was to analyze the demographic, clinical and laboratory characteristics and prognoses of children diagnosed with infectious mononucleosis (IM). The demographic features, referral complaints, clinical and laboratory findings, follow-up, and prognoses of 44 …
Continue reading at turkjpediatr.org (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56933—Mycoplasma
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/5695—Mycobacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56916—Enterobacteria, e.g. shigella, salmonella, klebsiella, serratia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells

Similar Documents

Publication Publication Date Title
Delavari et al. Impact of SARS-CoV-2 pandemic on patients with primary immunodeficiency
Azimi et al. Mumps meningoencephalitis in children
Cengiz et al. Infectious mononucleosis in Turkish children
Musher et al. Evolving understanding of the causes of pneumonia in adults, with special attention to the role of pneumococcus
Cattaneo et al. Production and persistence of specific antibodies in COVID-19 patients with hematologic malignancies: role of rituximab
Sterner et al. Acquired cytomegalovirus infection in older children and adults: A clinical study of hospitalized patients
Sauerbrei et al. Evaluation of three commercial varicella-zoster virus IgG enzyme-linked immunosorbent assays in comparison to the fluorescent-antibody-to-membrane-antigen test
Çağlar et al. Clinical features and laboratory findings in children hospitalized with acute Epstein-Barr virus infection: a crosssectional study in a tertiary care hospital
Tamir et al. Infectious Mononucleosis and Epstein Barr Virus in Childhood
Shi et al. Epidemiologic features of children with Epstein‐Barr virus associated diseases in Hangzhou, China
Nazon et al. Coronavirus disease 2019 3 months after hematopoietic stem cell transplant: a pediatric case report
Hassan et al. Risk factors for severe pneumonia in children in Basrah
Imashuku et al. Chlamydia pneumoniae infection-associated erythema multiforme
Mane et al. Outcome of COVID-19 in children with tuberculosis: Single-center experience
Esslami et al. COVID-19 in transplant recipient children: an Iranian referral hospital-based study
Majidy et al. Seroprevalence of Varicella zoster virus antibody among young women before marriage in Sanandaj, Iran
García-Peris et al. Epstein–Barr virus primary infection in healthy children
Melón et al. Involvement of adenovirus in clinical mononucleosis-like syndromes in young children
Da Cunha et al. Epstein-Barr virus reactivation causing cholestatic hepatitis
Ferronato et al. The role of respiratory virus infection in suspected pertussis: A prospective study
Barah et al. Prevalence of rubella IgG antibodies among Syrian females of childbearing age
Yoshida et al. Elucidation of the cross-reactive immunoglobulin M response to human herpesviruses 6 and 7 on the basis of neutralizing antibodies
Roy COVID-19 reinfection in the face of a detectable antibody titer
Rand et al. The Brief Case: Vaccine strain herpes zoster ophthalmicus and meningoencephalitis in an immunocompetent child
Rachna et al. Rubella serology in Indian adolescent girls and its relation to socio-economic status